Tocilizumab in Children With ACP
Condition: Adamantinomatous Craniopharyngioma Intervention: Drug: Tocilizumab Sponsors: University of Colorado, Denver; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2019 Category: Research Source Type: clinical trials
Neuromodulation for Hypothalamic Obesity
Conditions: Craniopharyngioma; Hypothalamic Obesity; Metabolic Syndrome Intervention: Device: Hypothalamic Deep Brain Stimulation Sponsor: University of British Columbia Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2018 Category: Research Source Type: clinical trials